| AICDA |
Q9GZX7
|
activation induced cytidine deaminase
|
Enzyme
|
9.2E-06 |
0.463 |
0.885 |
| AKT1 |
P31749
|
AKT serine/threonine kinase 1
|
Kinase
|
0.98 |
0.311 |
0.962 |
| ARR3 |
P36575
|
arrestin 3
|
Enzyme modulator
|
0.10 |
0.460 |
0.846 |
| ATM |
Q13315
|
ATM serine/threonine kinase
|
Kinase
|
5.6E-47 |
0.374 |
0.885 |
| BCL10 |
O95999
|
BCL10 immune signaling adaptor
|
|
0.34 |
0.491 |
0.769 |
| BCL2 |
P10415
|
BCL2 apoptosis regulator
|
Signaling
|
0.56 |
0.291 |
0.885 |
| BCL6 |
P41182
|
BCL6 transcription repressor
|
|
0.96 |
0.444 |
0.808 |
| CARD11 |
Q9BXL7
|
caspase recruitment domain family member 11
|
|
1.00 |
0.582 |
0.615 |
| CASP10 |
Q92851
|
caspase 10
|
Enzyme
|
4.6E-12 |
0.528 |
0.692 |
| CASP3 |
P42574
|
caspase 3
|
Enzyme
|
0.10 |
0.351 |
0.923 |
| CASP8 |
Q14790
|
caspase 8
|
Enzyme
|
3.7E-06 |
0.404 |
0.923 |
| CASR |
P41180
|
calcium sensing receptor
|
G-protein coupled receptor
|
4.7E-02 |
0.410 |
0.846 |
| CCND1 |
P24385
|
cyclin D1
|
Enzyme modulator
|
0.89 |
0.344 |
0.923 |
| CD19 |
P15391
|
CD19 molecule
|
|
0.90 |
0.430 |
0.885 |
| CDKN2A |
P42771 Q8N726
|
cyclin dependent kinase inhibitor 2A
|
|
0.39 |
0.300 |
0.885 |
| CLLS2 |
|
Disrupted in B-cell neoplasia
|
|
|
0.678 |
0.346 |
| CXADR |
P78310
|
CXADR Ig-like cell adhesion molecule
|
|
0.37 |
0.454 |
0.885 |
| CXADRP1 |
|
CXADR pseudogene 1
|
|
|
0.463 |
0.846 |
| CXCR4 |
P61073
|
C-X-C motif chemokine receptor 4
|
G-protein coupled receptor
|
1.8E-02 |
0.362 |
0.923 |
| CXCR5 |
P32302
|
C-X-C motif chemokine receptor 5
|
G-protein coupled receptor
|
0.73 |
0.524 |
0.769 |
| FAS |
P25445
|
Fas cell surface death receptor
|
|
0.81 |
0.372 |
0.923 |
| GPR34 |
Q9UPC5
|
G protein-coupled receptor 34
|
G-protein coupled receptor
|
0.26 |
0.743 |
0.346 |
| HLA-G |
P17693
|
major histocompatibility complex, class I, G
|
|
1.4E-11 |
0.461 |
0.769 |
| IGH |
|
immunoglobulin heavy locus
|
|
|
0.473 |
0.654 |
| IGHV3-69-1 |
|
immunoglobulin heavy variable 3-69-1 (pseudogene)
|
|
|
0.561 |
0.654 |